A progress update — the company is reporting how its raise is going (often that it hit its target).

Rejuve Biotech Inc.

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.